New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 9, 2014
05:51 EDTLIFE, DGXLife Technologies signs multi-year license, supply agreement Quest Diagnostics
Life Technologies (LIFE) has completed a multi-year license and supply agreement with Quest Diagnostics (DGX), the world's leading provider of diagnostic information services, that gives Quest rights to develop molecular tests on the Ion Torrent next-generation sequencing platform. Under the agreement, Quest may use the platform and related consumables to independently develop new tests for numerous areas of their business.
News For LIFE;DGX From The Last 14 Days
Check below for free stories on LIFE;DGX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2014
08:15 EDTLIFEEnzo Biochem announces August 18 as date of Markman hearing in lawsuit
Subscribe for More Information
July 25, 2014
08:32 EDTDGXQuest Diagnostics price target raised to $74 from $68 at Maxim
Subscribe for More Information
July 24, 2014
07:05 EDTDGXQuest Diagnostics narrows 2014 adjusted EPS view to $4.00-$4.10 from $3.95-$4.15
Subscribe for More Information
07:02 EDTDGXQuest Diagnostics reports Q2 adjusted EPS $1.08, consensus $1.06
Subscribe for More Information
July 22, 2014
07:08 EDTDGXLife Sciences highlights this week at Canaccord
Canaccord highlighted six diagnostic names that report this week and recommends buying Top Pick IDEXX (IDXX) into the print given strong recurring razor/razorblade sales and consistent organic growth. The analyst expects Hold rated Quest Diagnostics (DGX) to report upside to Street estimates of $1.06/$1.882B, Quidel (QDEL) to have an uneventful report, Exact Sciences (EXAS) to provide an update on numerous catalysts near-term and Abaxis (ABAX) to report earnings below consensus. Lastly, the firm is cautious on Meridian Bioscience (VIVO) following a competitor report last week.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use